These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2946984)

  • 1. [Mesoglycan sulfate in acute hemorrhoidal pathology].
    Saggioro A; Chiozzini G
    Minerva Med; 1986 Oct; 77(41):1909. PubMed ID: 2946984
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hemorrhoidal crisis with mesoglycan sulfate].
    Saggioro A; Chiozzini G; Pallini P; Di Gilio A; Betetto G; Scassola M; Pezzangora V
    Minerva Dietol Gastroenterol; 1985; 31(2):311-5. PubMed ID: 3162110
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evidence and rationale of mesoglycan to treat chronic venous disease and hemorrhoidal disease: a narrative review.
    Gallo G; Picciariello A; Tufano A; Camporese G
    Updates Surg; 2024 Apr; 76(2):423-434. PubMed ID: 38356039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids.
    Cospite M
    Angiology; 1994 Jun; 45(6 Pt 2):566-73. PubMed ID: 8203789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers.
    Arosio E; Ferrari G; Santoro L; Gianese F; Coccheri S;
    Eur J Vasc Endovasc Surg; 2001 Oct; 22(4):365-72. PubMed ID: 11563899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic trial of Percase and Percase-L suppositories in hemorrhoidal pathology].
    Héraud M; Paris JC
    Lille Med; 1967 Oct; 12(8):Suppl:842-6. PubMed ID: 4247109
    [No Abstract]   [Full Text] [Related]  

  • 7. [Instrumental evaluation of the effects of mesoglycan in venous disease patients. A prospective randomized double-blind study].
    de Donato G; Sangiuolo P
    Minerva Med; 1986 Oct; 77(41):1927-31. PubMed ID: 2946988
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of acute and chronic venous pathology of the extremities. Effect of mesoglycan in a case study of 50 patients].
    Florio A; Rosati V; Cioffi G
    Minerva Med; 1986 Oct; 77(41):1933-5. PubMed ID: 2946989
    [No Abstract]   [Full Text] [Related]  

  • 9. Daflon 500 mg in the treatment of hemorrhoidal disease: a demonstrated efficacy in comparison with placebo.
    Godeberge P
    Angiology; 1994 Jun; 45(6 Pt 2):574-8. PubMed ID: 8203790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized clinical trial of micronized flavonoids in the early control of bleeding from acute internal haemorrhoids.
    Khubchandani IT
    Tech Coloproctol; 2001 Apr; 5(1):57-8. PubMed ID: 11803925
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of mesoglycan therapy in patients with ischemia of the lower limbs. Preliminary results of a new therapeutic protocol].
    Raso AM; Maggio D; Trogolo M; Rispoli P; Sandrone N; Pezzuto D; Bellan A; Melloni CD
    Minerva Cardioangiol; 1997; 45(7-8):383-92. PubMed ID: 9463174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proteolytic enzymes in treating acute thrombophlebitis of hemorrhoidal nodes].
    Geller AN
    Khirurgiia (Mosk); 1972 Feb; 49(2):64-5. PubMed ID: 4572242
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical study of the Ginko biloba--Troxerutin-Heptaminol Hce in the treatment of acute hemorrhoidal attacks.
    Sumboonnanonda K; Lertsithichai P
    J Med Assoc Thai; 2004 Feb; 87(2):137-42. PubMed ID: 15061296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
    Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trihydroxyethylrutosides in the treatment of hemorrhoids of pregnancy: a double-blind placebo-controlled trial.
    Titapant V; Indrasukhsri B; Lekprasert V; Boonnuch W
    J Med Assoc Thai; 2001 Oct; 84(10):1395-400. PubMed ID: 11804247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, randomized clinical trial of troxerutin-carbazochrome in patients with hemorrhoids.
    Squadrito F; Altavilla D; Oliaro Bosso S
    Eur Rev Med Pharmacol Sci; 2000; 4(1-2):21-4. PubMed ID: 11409185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective effect of mesoglycan sulfate in venous thrombogenesis].
    Andreozzi GM; Signorelli S; Martini R; Palazzo V; Garozzo G; Sciuto V; Castorina L; Musumeci S
    Minerva Med; 1986 Oct; 77(40):1883-6. PubMed ID: 2946004
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical treatment of acute hemorrhoidal thrombosis and congestion with oxyphenbutazone. Our experience].
    Dávila SD; Viglione EE
    Prensa Med Argent; 1965 Oct; 52(36):2364-5. PubMed ID: 5879702
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of a minor fibrinolytic drug (mesoglycan) in phlebitis].
    Scondotto G; De Fabritiis A; Guastarobba A; Amato AC; Filippini M
    Minerva Med; 1984 Jul; 75(28-29):1733-8. PubMed ID: 6236381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathology and oral therapy of the hemorrhoidal syndrome].
    Aran Suau R; Aran Suau J; Sero Gonzalez J
    Rev Esp Enferm Apar Dig; 1971 Jan; 33(2):253-8. PubMed ID: 4930015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.